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Background: The creation of biobanks depends upon people’s willingness to donate their samples for research
purposes and to agree to sample storage. Moreover, biobanks are a public good that requires active participation
by all interested stakeholders at every stage of development. Therefore, knowing public’s attitudes towards
participation in a biobank and biobank management is important and deserves investigation.
Method: A survey was conducted among family members of patients attending the outpatient department of our
institute for a geriatric or neurological visit, documenting their willingness to participate in a biobank and their
views on the legal-ethical aspects of biobank management. Information regarding subjects’ attitudes on biomedical
research in general and genetic research in particular was also collected. Participants’ data on biobanks were
compared with data previously collected from the Italian ethics committees (ECs) to evaluate the extent to which
lay people and ethics committees share views and concerns regarding biobanks.
Results: One hundred forty-five subjects took part in the survey. The willingness to give biological samples for the
constitution of a biobank set up for research purposes was declared by 86% of subjects and was modulated by
subjects’ education. People in favour of providing biological samples for a biobank expressed a more positive view
on biomedical research than did people who were not in favour; attitude towards genetic research in dementia
was the strongest predictor of participation. Different from ECs that prefer specific consent (52%) and do not
choose the option of broad consent (8%) for samples collection in a biobank, participants show a clear preference
for broad consent (57%), followed by partially restricted consent (16%), specific consent (15%), and multi-layered
consent (12%). Almost all of the subjects available to contribute to a biobank desire to receive both individual research
results and research results of general value, while around fifty per cent of ECs require results communication.
Conclusion: Family members showed willingness to participate in a biobank for research and expressed a view on the
ethical aspects of a biobank management that differ on several issues from the Italian ECs’ opinion. Laypersons’ views
should be taken into account in developing biobank regulations.
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In recent years, biological banks have received much atten-
tion as a powerful tool to foster large-scale genetic research,
which may increase our knowledge of human beings and
hopefully will contribute to fighting diseases and improving
the quality of human lives.
Laypersons’ involvement in the biobanking enterprise
is crucial: the creation of biobanks depends upon subjects’
willingness to donate their samples for research purposes* Correspondence: cporteri@fatebenefratelli.it
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unless otherwise stated.and to agree to sample storage; moreover, controversial
projects of population biobanks have shown that not all
biobank projects are warmly received by all groups in so-
ciety and that biobanks are dependent on continual soci-
etal and political support to remain operational [1]. Finally
and most importantly, biobanks are a patrimony for the
present and future generations and should be regarded as
a public good. This requires active participation of all in-
terested stakeholders, including laypersons, at every stage
of development. Laypeople’s experiences and perceptions
need to count beyond the traditional expert opinion [2]
to avoid incorrect definitions of problems and to allow aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of linking biobanks with the views of citizens and pa-
tients should be researched [3,4], and in fact a variety of
approaches to increasing the role of public in the policy
and governance of science and biotechnology has
already been experienced [5], with the view of establish-
ing a more pluralistic and inclusive style of policy mak-
ing [6] that gives rise to a co-production of health and
knowledge. For these reasons, knowing the public’s atti-
tudes towards participation in a biobank and biobank
management is important and deserves investigation.
In this paper, we present the results of a survey con-
ducted among family members of patients attending the
outpatient department of our institute for a geriatric or
neurological visit, documenting their willingness to par-
ticipate in a biobank and their views on the legal-ethical
aspects of biobank management. A biobank for research
on dementia and psychiatric disorders is set up in our
institute. For this reason, the focus of our survey was on
biobanks set up at a local level—such as in university de-
partments, hospitals and scientific institutes—for pur-
poses of research. Nevertheless, because the boundaries
between different typologies of biobanks are somewhat
flexible, our results may apply to some extent to bio-
banks in general. We also collected information about
subjects’ attitudes regarding biomedical research in gen-
eral and genetic research in particular to better under-
stand our sample’s features and attitudes on different
types of biomedical enterprise. Data on biobanks col-
lected from participants, regarded as a sample of Italian
citizens, were compared with data previously collected
from the Italian ethics committees (ECs), to evaluate the
extent to which laypersons and ethics committees share
views and concerns on biobanks.
Method
Survey
A questionnaire-based survey was conducted among
family members who were assisting patients attending a
geriatric or neurological visit for cognitive impairment
or dementia at the outpatient department of our insti-
tute. Family members of patients consecutively referring
to the department were approached before their rela-
tives’ visit and were asked for consent to participate in
the survey after providing adequate information. None
of the subjects approached had previously taken part in
the constitution of a biobank. Only one member for
family unit took part in the survey. Patients could not
hear or interfere with the interview.
Three questionnaires were administered to the partici-
pants by a researcher not involved in the patients’ care
or in biobank management, while subjects were provided
with a copy of the questionnaires that they could follow
during the interview to facilitate comprehension. Basicsocio-demographic data were also collected. The survey
aimed to register subjects’ attitudes; no offer of participa-
tion either in a biobank or in any other type of research
project followed. The survey was carried out between May
and October 2011.
The IRCCS Fatebenefratelli ethics committee approved
the study.
Questionnaires
The three questionnaires, named in the order of submis-
sion, were about participants’ attitudes towards: i) bio-
medical research, ii) genetic research, and iii) biobank
participation and management.
The first questionnaire (9 questions) was translated
into Italian from the Research Attitudes Questionnaire
(RAQ) designed to measure how favourably or unfavour-
ably one views biomedical research in general [7].
The second (8 questions) was a questionnaire that we
developed to register participants’ views on genetic re-
search: three questions aim to measure the attitude to-
wards genetic research in general and specifically related
to psychiatric disorders and dementia through a 5-points
Likert scale; the others provide closed and exhaustive
answers. The questionnaire was used for the first time in
this study. Additional file 1.
The third questionnaire (17 questions) was adapted
from one that we developed and used in a study about
Italian ethics committees’ policies regarding the manage-
ment of the ethical aspects of biobanks. The initial ver-
sion of the questionnaire was tested for face validity
through submission to five researchers and four ECs
asked to comment on the clarity of the questions. A final
version of the questionnaire was developed after the test
and used in the study, demonstrating construct validity
(e.g. ability to discriminate between ECs of scientific
hospitals and of other clinical institutions). Forty-eight
ethics committees (ECs) took part in that study. Except
for the questions specifically related to ECs’ activities,
that were omitted, the questions used in this survey were
the same questions used in the previous study [8]. Only
people expressing their willingness to take part in a
hypothetical biobank completed the questionnaire on
the ethical aspects of the biobank management, which
was organised in the following areas: informed consent
(IC) and information for the subject; protection of confi-
dentiality; ownership of samples and data and intellec-
tual propriety rights (IPRs); communication of research
results; subjects’ remuneration and benefit sharing; access/
transfer of biological materials and related data; and length
of storage.
The time needed to complete the three questionnaires
was from 15 to 50 minutes depending on the individual
participant, with more than 50% of subjects completing the
questionnaires in less than 20 minutes. The questionnaires
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their comprehensibility and to remove ambiguities. In
particular, the second questionnaire was validated only
as regard “face validity” and no psychometric procedures was
applied before (e.g. criterion validity, test-rest reliability).
We observed that the first questionnaire (possible score
for each question range from 1 to 5, with higher scores in-
dicating a more favourable view) required multivariate
analysis to obtain more meaningful scores. Therefore, the
presence of distinct factors has been explored through fac-
torial analysis (Principal Component Analysis).
Results
Participation in a biobank
One hundred forty-five subjects took part in the survey.
On the basis of subsample analysis on 47 subjects, we
can consider that they represented about 80% of all of
the family members who were asked to participate. Their
demographic characteristics are presented in Table 1.
Age was symmetrically distributed around the average of
47.5 years, while females were clearly more represented
among family members who were assisting patients at-
tending a geriatric or neurological visit (75% vs. 25%).
High school was the median education level.
Factorial analysis of the first questionnaire allowed the
identification of three factors, able to explain 53% of the
total variance. Although this means that with three factors
a large percentage of variance (47%) remains specific of
single variables, Varimax rotation helped to clearly identify
their meaning. The first could be labelled “utility of re-
search” and was obtained by a linear combination of “dis-
covery of cures for major diseases” (factor loading = 0.77),
“personal utility” (factor loading = 0.63) and “protection of
participants’ interests” (factor loading = 0.52). The second
factor could be labelled “safety of research” and was ob-
tained by combining “emphasis on research and harm”
(factor loading = 0.81), “research is safe” (factor loading =
0.55) and “research does more good than harm” (factor
loading = 0.53). The third factor could be named “boost of
research” and was obtained by combining “positive view
on research” (factor loading = 0.78), “need to devote more
resources to research” (factor loading = 0.61) and (inversely)
“research needs to be regulated by government” (−0.64).
A total score, pulling together all the items of the ques-
tionnaire except “research needs to be regulated by gov-
ernment”, was also computed to have a unique index ofTable 1 Subjects’ socio-demographic features
M/F ratio 36/109 (75%)
Age, years 47.5 (11.1)
Mean (SD)
Education, years 13 (5–22)
Median (min-max)“attitude to research” (the Cronbach’s alpha was 0.65,
slightly below the conventional 0.70 threshold for ad-
equate internal consistency).
The willingness to provide biological samples for the
constitution of a biobank set up for research purposes
was declared by 125 subjects (86%), while 20 (14%) were
not available. Such large willingness was modulated nei-
ther by sex (p = 0.573) nor by age (p = 0.106) but by sub-
jects’ education, with the percentage of those participating
in a biobank rising from 69% among subjects with ≤8 years
of school to 92% in those with 13 years of school and to
100% in those with a university degree (chi-square = 18.8,
df = 2, p < 0.001).
People in favour of providing biological samples for a
biobank expressed a more positive view on biomedical
research than did people who were not in favour, mea-
sured by the scores of both the full questionnaire and
the three subscales (Figure 1). The differences between
those in favour and those who were not in favour are
quite similar in the three subscales (ANOVA, test for
interaction, p = 0.151), although we observed the largest
difference in terms of “safety of research”. To better ad-
dress this point we applied a multiple logistic regression
with “favour of giving samples for a biobank” as the
dependent variable and the three subscales of the first
questionnaire as covariates. We found that, even after
adjusting for education effect, each subscale gave a sig-
nificant contribution to the biobank participation (utility:
OR = 3.9, 95% CI: 1.2-13.4; boost: OR = 5.6, 95% CI: 1.2-
26.7; safety: OR = 8.2, 95% CI: 2.1-31.4). In other words,
higher scores of each factor increased the probability of
being available to participate in a biobank.
Subjects expressed a favourable attitude (possible scores
for each question range from 1 to 5, with higher scores in-
dicating more favourable views) toward genetic research
in general (4.06, SD = 0.47) and genetic research related to
psychiatric disorders (4.09, SD = 0.49) and dementia (4.16,
SD = 0.54). Even if indexes of central tendency are consist-
ently above 4, significant differences were found (Friedman
nonparametric related samples ANOVA, p = 0.004), with
scores of attitude toward genetic research in dementia be-
ing higher than the others (Bonferroni corrected p < 0.035).
As expected, the scores of three attitudes toward genetic
research are significantly correlated with each other (the
lowest correlation was between attitude toward genetic re-
search in general and genetic research in dementia, which
was equal to 0.58, p < 0.001). However, according to logis-
tic regression, scores of attitude toward genetic research
in general does not “predict” the propensity to participate
in a biobank (p = 0.109), while both scores of attitudes
towards specific genetic research were more closely as-
sociated with biobank participation (p < 0.001). The
multivariable analysis indicated that attitude toward
genetic research in dementia is the strongest predictor
Figure 1 Scores (means and 95% confidence intervals) on the full questionnaire and on the three subscales, according to willingness/
unwillingness of providing biological samples for a biobank. Higher scores were consistently observed in participants willing to
biobank participation.
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taking into account education and scores of the first
questionnaire: we estimated that for each 1-point in-
crease the adjusted odd of being available to partici-
pate increased by 5.5 times (95% CI: 1.6-18.3).
Subjects also expressed a large willingness to take part
in genetic research in general (77%), genetic research re-
lated to psychiatric disorders (75%), and dementia (77%),
without any significant difference among them (Cochran
test, p = 0.646). As expected, the relationship between
such willingness and participation in a biobank was sig-
nificant (p < 0.001 in all cases). In more detail, almost all
of the subjects who were in favour of taking part in gen-
etic research expressed an intention to participate in a
biobank (>96%), while a percentage ranging from 44% to
53% of subjects who were not in favour of genetic re-
search would participate in a biobank.
The major reasons for taking part in genetic research
in general were to help in increasing knowledge and
possible benefits for future generations (76%) as well as
a possible benefit for a relative (42%). The major reasons
for not being available for genetic research were, first, a
fear of discovering possible genetic predisposition to cer-
tain diseases (49%)—this reason increases in research re-
garding psychiatric disorders (58%) and dementia (66%),
and second, a worry that genetic materials may be used
against personal principles (21%) or for commercial pur-
poses (21%). Another important reason for not taking
part specifically in research on psychiatric disorders anddementia was a worry that the genetic information may
be used for discriminatory purposes (25% and 22%).
In addition, subjects were asked about their agreement
on their relatives’ participation in genetic research on
dementia: 105 subjects (72%) were in favour; those who
were not in favour mainly showed a wish to protect the
patient (42%) who was regarded as too old, not able to
decide, or not able to benefit from the research.
Opinion on the ethical aspects of biobanks
Regarding the ethical aspects of a biobank management,
subjects answered as follows on the investigated areas.
The full questionnaire was completed by 122/125 subjects.
All percentages are expressed as percent of non-missing
values.
1. Informed consent and information provided to
the subjects
Subjects were asked which type of IC for research
on biological materials they would be willing to give
(more than one option could be selected). The
different types of consent [9] included the following
options: (1) broad consent, which allows the use of
biological specimens and related data for current
research and future investigations of any type at any
time; (2) partially restricted consent, which allows
the use of biological specimens and related data for
specific current research and future investigations







Porteri et al. BMC Medical Ethics 2014, 15:81 Page 5 of 10
http://www.biomedcentral.com/1472-6939/15/81projects; (3) multi-layered consent, which
requires several options to be explained to the
research subject in a detailed form; and (4) specific
informed consent, which allows the use of
biological specimens and related data only for
current research and forbids use for any future
study that is not foreseen at the time of the
original consent.
Participants showed a clear preference for broad
consent (57%), followed by partially restricted consent
(16%), specific consent (15%), and multi-layered
consent (12%) (Table 2). The comparisons between
the public and ECs indicate clear differences for each
type of consent, with public participants favouring
broad consent (Fisher’s exact test, p < 0.001) and ECs
favouring the other types of consent (p = 0.002 for
partially restricted, p = 0.059 for multi-layered, p < 0.001
for specific). It should be noted that the answers were
not mutually exclusive; thus, the percentages for each
column can sum above 100% (although public
participants chose only one answer) and, accordingly,
statistical tests were applied for each type of consent.
A large majority of participants (86%) believe
informed consent should be given in a written
form, while the others regard oral informed
consent as also acceptable, whether documented or
not. Subjects who do not choose broad informed
consent want to be contacted again for the use of
their samples in investigations not included in the
original IC form (93%).
Table 3 shows the type of information subjects (123/125
answered to this question) regard as important to
receive when consent is collected. The comparisons
between public and ECs are also reported.
In participants’ views (122/125), withdrawal of
consent from the biobank should lead to sample
destruction (58%), sample anonymisation (25%),
or prohibition on using the sample in new
research (7%).
2. Protection of confidentiality
Regarding samples and data processing within the
centre that collected them to protect subjects’ right
to privacy, participants prefer the use of a code that
makes it possible to later determine the donor’sble 2 Models of informed consent chosen by the public
d by the Italian ECs
Public ECs
N =125 N = 48
oad consent 71 (57%) 4 (8%)
rtially restricted consent 20 (16%) 18 (38%)
ulti-layered consent 15 (12%) 12 (25%)
ecific consent 19 (15%) 25 (52%)identity (97%) to the anonymous use of samples
(i.e., the irreversible removal of the link with the
donor).
3. Communication of research results
People who are ready to donate biological materials
for biobank constitution also wish to be informed
about the research results, both of general value
(96%), through direct contact or publication, and of
individual interest (98%), with a preference for
results relevant to the donor’s health or family
members’ health. Participants’ attitudes on the topic
and those of ECs are compared in Table 4. Forty-three
subjects (35%) want their research results to also be
communicated to family members; 8 (19%) of them
ask for communication to family members only if
results are relevant for health.
4. Access/transfer of biological materials and related data
Subjects were asked about access to samples and
data by researchers who are not related to the
centre that collected the biological materials. The
large majority of participants regard access to
samples by not-for-profit organisations (86%) as
permissible, while only a minority (30%) agrees with
access from for-profit organisations. In participants’
view, the access/transfer of biological materials and
related data to both not-for-profit and for-profit
organisations should be subjected to conditions,
mainly regarding the impossibility of these bodies
to identify the donor (37%) and the favourable
opinion of the relevant ethics committee (34%)
(Table 5).
5. Propriety of samples, IPRs and remuneration
The majority of subjects believe the research/
biobank sponsor should be the owner of the
samples (69%) and should be entitled to
intellectual propriety rights (IPRs) (67%), while
donors should maintain sample propriety and IPRs
respectively for 21% and 2% of the subjects. For 25
subjects (20%) IPRs should be shared between
sponsor and donors, and for 7% of the subjects the
income derived from the use of biological samples
should be reinvested in research.
Regarding donors’ remuneration to take part in a
biobank, the large majority (87%) think donors
should not be remunerated for taking part in a
biobank; the others agree with remuneration, but
exclusively as a flat refund and refund for
documented expenses.
6. Duration of the storage
The majority (51%) of subjects who answered the
question do not care about the duration of sample
storage and data preservation, while 36% express a
preference for an open-ended period, and 13% for a
limited period.
Table 3 Key information for informed consent: public and ECs opinion ordered from the more to the less important in
the public’s view
Public ECs Fisher Exact test
N = 123 N =48 P-value
Type of biological materials taken for a biobank creation 111 (90%) 44 (92%) 1.000
Purpose for which biological materials will be used 110 (89%) 48 (100%) 0.021
Communication of research results 104 (85%) 21 (44%) 0.000
Prohibition of the commercialisation of samples and related data 98 (80%) 24 (50%) 0.000
Right to withdraw consent to the use of samples 98 (80%) 47 (98%) 0.002
Right to withdraw consent to the use of data 97 (79%) 42 (89%) 0.275
Authorisation to be recontacted 86 (70%) 30 (63%) 0.367
Rules to protect subjects’ privacy 83 (67%) 46 (96%) 0.000
Independent ethics committee review 65 (53%) 18 (38%) 0.089
Transfer of samples and related data to other research institutes 65 (53%) 31 (65%) 0.175
Authorisation to contact family members 62 (50%) 11 (23%) 0.001
Access to samples and data from external researchers 59 (48%) 26 (54%) 0.499
Destiny of samples and data in case of advanced research conclusion 58 (47%) 25 (52%) 0.612
Solidarity character of the participation 53 (43%) 36 (75%) 0.000
Information on Intellectual Property Rights and patents 53 (43%) 20 (42%) 1.000
Location of biological materials collection 48 (39%) 37 (77%) 0.000
Destiny of samples and data after donor’s death 41 (33%) 17 (35%) 0.858
Information on the property of samples 40 (33%) 25 (52%) 0.023
Duration of the storage 35 (28%) 32 (67%) 0.000
Benefit-sharing 0 (0%) 3 (6%) 0.021
Significant (p < 0.05) differences between public and ECs were highlighted.
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The large majority of subjects who were asked to partici-
pate in the survey gave consent. Moreover, people who
decided not to participate provided reasons more related
to logistics than to ideological issues. This large partici-
pation is an initial demonstration of laypersons’ wish to
take an active part in the construction of knowledge. It
also assures that our sample’s opinion is representative
of the target population, i.e. family members of patients
suffering from dementia or cognitive impairment.Table 4 Communication of research results: public and ECs op
Research results of general va
Public ECs
N = 117/122 (96%) N = 26/4
Web site 40 (34%) 4 (15%)
Direct contact 60 (51%) 12 (46%)
Publication 17 (15%) 14 (54%)
Any type of individual results
Only health relevant individual results
P-value (Fisher Exact test) also reported.The percentage of participants who expressed the will-
ingness to provide biological materials for the constitution
of a biobank is among the highest registered in attitude
surveys [10]. The study was related to a hypothetical
willingness of participating in a biobank: a request for
real involvement in a biobank constitution could pro-
vide a different, but not necessarily lower, rate. Studies
suggest factual willingness to participate in biobank re-
search may be greater than hypothetical, in particular
when donors are recruited in health care facilities andinion
lue/yes Individual results/yes Fisher exact test
Public ECs p-value




45 (38%) 9 (39%) 1.000
74 (62%) 13 (57%) 0.645
Table 5 Conditions expressed by participants for the
access to samples and data collected in a biobank from
others research organizations
Conditions %
Ethics committee’s opinion 34%
Use only for a specific research 7%
Destruction of the remaining biological materials 8%
Return of the remaining biological materials to the first biobank 18%
Impossibility for the organizations to identify the donor 37%
Constitution of a biobank 8%
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in the hypothetical context, such as altruism, trust and
sense of duty [10]. In our study, the aspect of hypothet-
ical participation and the element of motivation due to
subjects’ specific situation are combined.
The willingness to participate in the constitution of a
biobank was modulated by subjects’ years of schooling,
as other surveys found [11], confirming the common,
although controversial, idea that higher education con-
tributes to giving people more confidence in science.
Results show that subjects’ attitudes towards biomedical
research can predict their attitudes towards participation
in the constitution of a biobank, with people expressing a
more positive feeling on biomedical research, and particu-
larly on the safety of research, being more available to
personally take part in a biobank. The result is also true
regardless of the subject’s years of schooling, suggesting that
not only education but also individual feeling, i.e., some-
thing not necessarily related to formal education or scien-
tific knowledge, counts in expressing this choice.
The attitude towards genetics research on dementia was
the strongest predictor of subjects’ participation in a bio-
bank, even taking into account subjects’ education and
feelings about biomedical research as expressed in the first
questionnaire. These data support the intuitive perception
that personal proximity to a disease and the suffering it
causes the patients and their relatives makes people more
aware and sensitive to the need for research and is the
strongest motivation to accept direct involvement in re-
search. The active promotion of research by patients and
family members’ associations confirms this point [12].
People who were not available for genetic research
manifested a fear of discovering a genetic predisposition
to certain diseases, particularly to dementia. This indicates
a potential conflict among the family members of people
affected by a disorder: on the one hand, there is an in-
creased motivation in contributing to the advancement of
knowledge and the possibility of cure and, on the other
hand, there is an increased fear of discovering a personal
predisposition to the disease. We believe that the fact that
psychiatric disorders and dementia are very often the ob-
ject of social stigma [13] contributes to the worry thatgenetic information may be used for discriminatory
purposes.
The percentage of people who were not available for
genetic research but expressed willingness to take part
in the constitution of a biobank may perhaps be explained
by the idea that giving a sample to a biobank is less de-
manding than being actively involved in research. Anyway,
a misunderstanding of the typical type of research carried
out in a biobank cannot be excluded.
Our work was also designed to collect lay subjects’
opinion on the ethical and legal aspects of the manage-
ment of biobanks and to compare their views with ex-
perts’ view, namely, with ethics committees’ opinions.
The results showed that on several issues the Italian ECs
and our sample of the public did not share the same
view, even though the ECs are made up of members
with different expertise, including patients’ representa-
tives [14], and may be regarded, at least from an ideal
perspective, as an expression of civic participation in the
scientific enterprise.
The most relevant result concerns the model of IC and
the pertinent information chosen by the ECs and the pub-
lic. Informed consent is the most crucial and discussed
element in the constitution of biobanks [15], where bio-
logical samples are collected at a certain point in time and
then used for a long period of time, with research methods
and opportunities rapidly evolving, which makes it diffi-
cult to give the subjects full information at the time of
sample collection. The marked difference between the
type of IC for research on biological materials that ECs re-
gard as suitable and the type of IC that family members
are willing to give may be partially due to a different
awareness of the complexity of the ethical and legal issues
related to IC among lay people and ECs. This interpret-
ation seems to be confirmed by lay people’s tendency not
to choose the more complex model of IC, namely, multi-
layered consent. Nevertheless, public’s preferences cannot
be simply ascribed to a lack of knowledge and awareness
or to the desire not to be too much involved in demanding
activities. On the contrary, the public seems to be more in
line with researchers’ common idea that broad consent is
essential to facilitate research opportunities and therefore
scientific advancement. Other studies investigating differ-
ent consent options found that most people are willing to
provide one-time general consent for research [16], but
different opinions were also registered [17]. The findings
of the Eurobarometer survey EB 73.1 ‘Life Sciences and
Biotechnology’, which took place in 2010 and contained
questions on biobanks [18], showed that the option of
broad consent appears not to be supported by the general
public in Europe. People were invited to say which kind of
permission they thought was needed when a scientist does
research on data in a biobank among: not need to ask for
permission (unrestricted consent), ask for permission only
Porteri et al. BMC Medical Ethics 2014, 15:81 Page 8 of 10
http://www.biomedcentral.com/1472-6939/15/81once (broad consent), ask for permission for every new
piece of research (specific consent), don’t know. Data re-
lated to Italy show that 7% of the public thinks there is no
need to ask for permission, 21% is in favour of giving
permission only once, while 58% is in favour of giving
permission for every new piece of research. Interest-
ingly, attitudes in Europe towards broad consent are
also shaped by the levels of information, with people
who know more about biobanks being more willing to
give broad forms of consent [11]. Moreover, those who
say they will definitely participate in a biobank are much
more likely to say researchers don’t need to ask for per-
mission (16%) or permission granted once only (28%).
We did not assess subjects’ level of information on bio-
banks, but it cannot be excluded that people attending
hospitals and who are involved in patients’ caregiving
know more than the general public about research on
biological materials. In addition, our data on IC prefer-
ences refer only to people who expressed willingness to
participate in a biobank.
Public and ECs opinions also differ to some extent re-
garding the key information to be provided to the subjects
[Table 3], with the public showing a tendency toward a
greater interest in the aspects related to the relationship
between researchers and donors, i.e., the authorisation to
be re-contacted and to contact family members as well as
the communication of research results. Subjects’ interest
in the communication of research results is reiterated by
almost all subjects’ desire to receive both individual results
and research results of general value, while only around
fifty per cent of ECs require results communication
[Table 4]. This subjects’ expectation is confirmed in other
surveys [19], returning research results is regarded as an
influential factor in subjects’ decision to become biobank
donors [20], and researchers endorse the obligation of
communicating with research participants [21]. Anyway,
there are a wide-ranging views and practices regarding the
return of individual research results to participants [22].
Our participants’ request is in line with the ethical duty to
return genetic research results of significance for the indi-
vidual subject stated in international regulations [23], and
with the subjects’ right to ask for their results of any type
and to obtain them if they wish [24]. While ECs position
may reflect the worry that the communication of research
results that may be not informative enough for the indi-
vidual subject and for which interpretation is difficult may
generate misunderstanding and confusion for the subjects.
Family members are not really interested in informa-
tion regarding sample property and IPR; in fact, around
70% of the subjects believe that the sponsor should be
the owner of samples and IPR. On the contrary, those
interviewed are greatly interested in having information
about the sponsor’s prohibition on commercialising the
samples and related data, which in addition they thinkshould be given for free by the donors. Moreover, the
large majority of the public regards the access of samples
by not-for-profit organisations as acceptable, but only a
minority agrees with access by for-profit organisations;
on the contrary, ECs did not express a difference in
opinion between the possibility of access from for-profit
and not-for-profit organisations, both regarded as ac-
ceptable by around 70% of ECs. All these data converge
in supporting a subjects’ disinterested view on their pos-
sible personal economic profit, that they ask be repaid
with a similar approach by research promoters. The fact
that people do not expect economic gain from participa-
tion in biobanks does not mean that they do not have an
expectation of getting something in return [25]. From
our sample’s responses, the desired reward seems to be
primarily a good relationship with researchers who are
asked to look at donors as active speakers who contrib-
ute to increasing present knowledge and the possibility
of cure in the future and who are entitled to be informed
of the research results and to be protected against
discrimination.
Limitations
The questionnaire on the attitudes towards genetic re-
search was developed and used for the first time in this
study, thus it was not validated in a previous and inde-
pendent sample.
We did not formally check the participants’ level of
knowledge and information on biobank. Therefore we
could not evaluate if this influenced family members’
willingness to participate in a biobank constitution and
their opinion on the ethical aspects of biobank management.
Participants were family members of patients attending
a geriatric or neurological visit. At this stage of the project,
patients were not involved in the survey. To investigate
possible differences between the attitudes of patients and
those of family members would be interesting, to evaluate
how being affected by a disorders can shape willingness
and opinions. Alternatively, a comparison among the atti-
tudes of family members of patients affected from differ-
ent kind of disorders could help to understand if different
pathologies (affecting the brain or the body, with or with-
out a possible treatment, for which we have or not know-
ledge of the causes) might influence people’s responses.
Finally, we acknowledge that our sample cannot be
regarded as representative of the general public because
it consists of the family members of patients suffering
from a specific disturbance, and they were interviewed
in an outpatient medical department. Both of these cir-
cumstances could influence their answers.
Conclusion
We presented a survey conducted among the family mem-
bers of patients who attended our institute for cognitive
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views regarding biobank participation and management.
We also collected elements to understand subjects’ atti-
tudes towards medical research and genetic research and
to delineate the features of the subjects available to take
part in a biobank. The subjects’ and Italian ECs’ opinions
on the ethical aspects of biobank management were then
compared.
The so-called general public is made up of different
publics invited to have a voice. In this sense, even though
our sample is not representative of the general public, our
subjects are one public and because they have a proximity
with a disease that can be studied using genetic research
and biobanks, they represent a public that is particularly
qualified for expressing an opinion on the matter.
In the light of our findings, we believe that in developing
biobank regulations, both ECs and policy makers should
take into account not only expert opinions but also the
views of lay people, on whom the possibility of the success
of biobanks ultimately rests.Additional file
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